5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 26.22▼ | 26.22▼ | 25.33▲ | 25.58▲ | 24.16▲ |
MA10 | 26.29▼ | 25.13▲ | 24.86▲ | 24.81▲ | 24.97▲ |
MA20 | 26.34▼ | 24.97▲ | 25.37▲ | 23.74▲ | 27.14▼ |
MA50 | 25.25▲ | 25.76▲ | 25.34▲ | 25.63▲ | N/A |
MA100 | 25.05▲ | 25.06▲ | 24.06▲ | 27.45▼ | N/A |
MA200 | 25.64▲ | 23.94▲ | 24.26▲ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.107▼ | 0.283▲ | 0.093▲ | 0.434▲ | -0.305▼ |
RSI | 51.699▲ | 58.244▲ | 56.130▲ | 55.828▲ | 47.699▼ |
STOCH | 30.855 | 80.121▲ | 46.088 | 69.305 | 24.420 |
WILL %R | -100.000▼ | -21.708▲ | -21.479▲ | -27.065 | -69.553 |
CCI | -156.663▼ | 93.486 | 95.092 | 72.132 | -23.411 |
Monday, February 22, 2021 01:10 PM
Avidity Biosciences announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself ...
|
Thursday, February 18, 2021 12:43 AM
LA JOLLA, Calif., Feb. 17, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody ...
|
Wednesday, February 17, 2021 01:05 PM
LA JOLLA, Calif., Feb. 17, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/03/21 | 25.66 | 26.67 | 25.51 | 26.06 | 226,758 |
26/02/21 | 25.62 | 26.7099 | 23.81 | 24.13 | 743,977 |
25/02/21 | 26.11 | 26.91 | 25.29 | 25.41 | 313,599 |
24/02/21 | 26.71 | 27.6779 | 25.78 | 26.02 | 331,122 |
23/02/21 | 26.61 | 27.00 | 25.665 | 26.28 | 496,993 |
22/02/21 | 26.76 | 27.435 | 26.41 | 26.75 | 699,003 |
19/02/21 | 22.35 | 27.24 | 22.23 | 25.87 | 2,034,165 |
18/02/21 | 22.39 | 22.6199 | 21.70 | 22.24 | 275,283 |
17/02/21 | 23.01 | 23.25 | 22.20 | 22.39 | 165,815 |
16/02/21 | 22.75 | 23.66 | 22.5017 | 22.95 | 346,479 |
|
|
||||
|
|
||||
|
|